期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (3)
Objective: Gaucher disease (GD) is a rare disorder linked to the absence/deficiency of glucocerebrosidase. GD can be treated by enzyme replacement the......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Objectives: We aimed to evaluate the high-quality literature on the frequency and nature of major adverse cardiac events (MACE) associated with either......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Objective: The objective of the study is to describe and analyze the pharmacodynamics and pharmacokinetics of oteseconazole as well as the clinical ev......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Background: Stenotrophomonas maltophilia is an opportunistic, gram-negative bacillus with few therapeutic options due to a high level of intrinsic res......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (2)
Background Hepatic encephalopathy (HE) is a complication of cirrhosis. Rifaximin, added to lactulose, effectively maintains remission and reduces hosp......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (4)
Background: Anxiety and chronic pain are common comorbidities in patients with chronic obstructive pulmonary disease (COPD), which are frequently mana......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Background: Vancomycin Bayesian modeling provides 24-hour area under the curve (AUC24) estimations. However, the agreement between two-concentration a......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (3)
Objective: To review the current pharmacology, pharmacokinetics/pharmacodynamics, safety, and efficacy of inclisiran in lowering lipid levels. Data So......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (3)
Objective: The main objective of this article is to review the immunogenicity and safety of the 3-antigen recombinant hepatitis B vaccine (3A-HepB) in......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (4)
Objectives: To review the characteristics, efficacy, safety, pharmacoeconomics, and place in therapy of upadacitinib, a Janus kinase (JAK) inhibitor, ......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (11)
Background: Hypertriglyceridemia-associated acute pancreatitis is a disease lacking a standardized management approach. Objective: The main objective ......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Background: The preferred carbapenem for treatment of infections caused by extended spectrum beta-lactamase-producing Enterobacterales (ESBL-E) in cri......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; ()
Objective: To review the efficacy and safety of eculizumab for prevention and treatment of antibody-mediated rejection (AMR) in lung transplant recipi......
期刊： ANNALS OF PHARMACOTHERAPY, 2023; 57 (3)
Objective To review the pharmacokinetics, efficacy, and safety of recently approved calcipotriene and betamethasone dipropionate (C-BD) cream. Data so......
